Uruguay is taking its time with the implementation of its legal, regulated recreational cannabis sales — something that has been delayed a number of times by the nation’s government. But now there’s a new twist to the South American country’s plan, one that will surprise legalization advocates and anti-pot opposition alike.

One reason that kind of pricing comes off as odd: The government would be charging more for medicine than they would drugs meant for recreational use, indicating an unusual emphasis. Another reason: It goes against everything the legalization movement has seen in the U.S., where medical prices are often half of their recreational counterparts in Colorado and Washington shops.

The reason, according to The Global Post:

Medical marijuana will be grown separately from the recreational type, by different companies. It will likely have higher levels of tetrahydrocannabinol or THC, the plant’s chemical compound that makes users high, and will be grown under stricter controls than pot grown purely for fun.

The Global Post spoke with Montevideo-based Diego Canepa, president of Uruguay’s National Drug Council, about the supposed pricing. He said it’s too early to tell what the country will be charging for medical or recreational marijuana.

“I don’t know how anyone can say that right now,” Canepa told the paper. “It’s impossible to know.”

While the possession of cannabis has been federally legal in Uruguay since 1974, the government’s recent effort to regulate the sale of recreational marijuana — a feat that is still in the somewhat distant future — has thrust the quiet, modest country of 3.3 million into the international limelight.

Ricardo Baca is a contributing editor for The Cannabist. He was appointed The Denver Post's first marijuana editor in November 2013 and spearheaded the formation of The Cannabist, a division of the Post. Fortune magazine ranked Baca as one of the...